Bone graft substitutes

Operative Techniques in Plastic and Reconstructive Surgery

Volumn 9, Issue 4, 2002, Pages 151-160

  Ilan, Doron I ^a   Ladd, Amy L ^a,b  

^a Robert A Chase Hand/Upper Limb Ctr   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APATITE; AUTOLOGOUS GRAFT FACTOR SYSTEM; BONE CEMENT; BONE MORPHOGENETIC PROTEIN; CALCIUM PHOSPHATE; CALCIUM SULFATE; CELL SAVER 5; COLLAGEN; CYTOKINE; DRUG CARRIER; ETHYLENE OXIDE; FIBROBLAST GROWTH FACTOR; GELATIN; GLASS; GLYCEROL; GROWTH FACTOR; HYALURONIC ACID; HYDROXYAPATITE; INFUSE; OSSIGEL; OSTEOGENIC PROTEIN 1; PEPTIDE; PLASMA PROTEIN; PLATELET DERIVED GROWTH FACTOR; POLY(METHYL METHACRYLATE); POLYMER; PROPYLENE OXIDE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; ROSEOLIC ACID; STEARIC ACID; SYMPHONY PLATELET CONCENTRATION SYSTEM; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG; VASCULOTROPIN; WATER;

AUTOGRAFT; BONE MINERAL; BONE TRANSPLANTATION; CERAMICS; CLINICAL TRIAL; DONOR; HUMAN; MEDICAL INFORMATION; MORBIDITY; OPERATION DURATION; REVIEW; SIDE EFFECT; STANDARD; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0347765908     PISSN: 10710949     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.otpr.2003.09.003     Document Type: Article

References (53)

1. Boden SD: Osteoinductive bone graft substitutes: Burden of proof. Bull Amer Acad Orthoped Surg 51(1):42-43, 2003
2. Friedlaender GE, Goldberg VM (eds): Bone and Cartilage Allografts: Biology and Clinical Applications. American Academy of Orthopedic Surgeons: Park Ridge, IL, 1991
3. Younger EM, Chapman MW: Morbidity at bone graft donor sites. J Orthop Trauma 3:192-195, 1989
4. Ladd AL, Pliam NB: The use of bone graft substitutes in distal radius fractures. J Amer Acad Orthop Surg 7:279-290, 1999
5. Blobe GC, Schiemann WP, Loish HF: Role of transforming growth factor β in human disease. N Engl J Med 342:1350-1358, 2000
6. Schmitt JM, et al: Bone morphogenetic proteins: an update on basic biology and clinical relevance. J Orthop Res 17:269-278, 1999
7. Kawabata M, Imamura T, Miyazono K: Signal transduction by bone morphogenic proteins. Cytokine Growth Factor Rev 8:49-61, 1998
8. Lieberman JR, Daluiski A, Einhorn TA: The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg 84A:1032-1044, 2002
9. Ladd AL, Pliam NB: The role of bone graft and alternatives in unstable distal radius fracture treatment. Orthop Clin N Amer 30:337-351, 2001
10. Centers for Disease Control and Prevention: Update: Allograft-associated bacterial infections - United States, 2002. MMWR 51:207-210, 2002
11. Epidemiologic notes and reports transmission of HIV through bone transplantation: case report and public health recommendations, Oct 7, 1988, MMWR
12. Urist MR, et al: The bone induction principle. Clin Orthop 53:243-283, 1967
13. Bostrom MP, et al: An unexpected outcome during testing of commercially available demineralized bone graft materials: How safe are the nonallograft components? Spine 26:1425-1427, 2001
14. Truumees E, Herkowitz HN: Alternatives to autologous bone harvest in spine surgery. Univ of Pennsylvania Orthoped J 12:77-88, 1999
15. Werber KD, et al: Osseous integration of bovine hydroxyapatite ceramic in metaphyseal bone defects of the distal radius. J Hand Surg 25A:833-841, 2000
16. Shors EC: Coralline bone graft substitutes. Orthop Clin North Amer 30:599-613, 1999
17. McCalden RW, McGeough JA, Court-Brown CM: Age-related changes in the compressive strength of cancellous bone. The relative importance of changes in density and trabecular architecture. J Bone Joint Surg 79A:421-427, 1997
18. Bucholz RW, Carlton A, Holmes R: Interporous hydroxyapatite as a bone graft substitute in tibial plateau fractures. Clin Orthop 240:53-62, 1989
19. Wolfe SW, et al: Augmentation of distal radius fracture fixation with coralline hydroxyapatite bone graft substitute. J Hand Surg 24A:816-827, 1999
20. Toth JM, et al: Evaluation of porous biphasic calcium phosphate ceramics for anterior cervical interbody fusion in a caprine model. Spine 20:2203-2210, 1995
21. Resnick DK: Vitoss bone substitute. Neurosurgery 50:1162-1164, 2002
22. Chronos FDA approval, 2002
23. Hinz P, et al: A new resorbable bone void filler in trauma: early clinical experience and histologic evaluation. Orthopedics 25:s597-s600, 2002
24. Dreesman H: Ueber Knochenplombierung. Bietr Klin Chir 9:804-810, 1892
25. Peltier LF: The use of plaster of Paris to fill large defects in bone. A preliminary report. Am J Surg 97:11-15, 1959
26. Proposed Rules 5753-5756. Orthopedic Devices; Proposed Classification for the Resorbable Calcium Salt Bone Void Filler Device, Feb 7, 2002, Federal Register Docket # 01N-0411/Vol. 67, No. 26
27. Kelly CM, et al: The use of a surgical grade calcium sulfate as a bone graft substitute: results of a multicenter trial. Clin Orthop 382:42-50, 2001
28. Constantz BR, et al: Skeletal repair by in situ formation of the mineral phase of bone. Science 267:1796-1799, 1995
29. Yetkinler DN, et al: Biomechanical evaluation of intraarticular distal radius fracture treatment stability: K-wires vs calcium phosphate bone cement. J Bone Joint Surg 81A:391-399, 1999
30. Vaes G: Cellular biology and biochemical mechanism of bone resorption. A review of recent developments on the formation, activation, and mode of action of osteoclasts. Clin Orthop 231:239-271, 1988
31. Frankenburg EP, et al: Biomechanical and histological evaluation of a calcium phosphate cement. J Bone Joint Surg 80A:1112-1124, 1988
32. Jupiter JB, et al: Repair of five distal radius fractures with an investigational cancellous bone cement: a preliminary report. J Orthop Trauma 11:110-116, 1997
33. Cassidy C, et al: Norian SRS vs conventional therapy in distal radius fractures: Multicenter study of 323 patients. J Bone Joint Surg, in press
34. Wolff J: The Law of Bone Transformation. New York, Springer-Verlag, 1986
35. Dickson KF, et al: The use of BoneSource hydroxyapatite cement for traumatic metaphyseal bone void filling. J Trauma 53:1103-1108, 2002
36. Knaack D, et al: Resorbable calcium phosphate bone substitute. J Biomed Mater Res 43:399-409, 1998
37. Hench LL, Paschall HA: Histochemical Responses at a Biomaterials Interface. J Biomed Mater Res 5:49-54, 1974
38. Oonishi H, et al: Particulate bioglass compared with hydroxyapatite as a bone graft substitute. Clin Orthop 334:316-325, 1997
39. Charnley J: The healing of human fractures in contact with self-curing acrylic cement. Clin Orthop 47:157-163, 1966
40. Scaglione PH, Buchman MT: Collagraft bone substitute in upper extremity fractures: a preliminary study. Surg Forum Amer Coll Surg XLVIII:563-564, 1997
41. Chapman MW, Bucholz R, Cornell C: Treatment of acute fractures with a collagen-calcium phosphate graft material. A randomized clinical trial. J Bone Joint Surg 79A:495-502, 1997
42. Wagers AJ, et al: Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 297:2256-2259, 2002
43. Muschler GF, et al: Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res 19:117-125, 2001
44. Muschler G, Midura RJ: Connective tissue progenitors: practical concepts for clinical applications. Clin Orthop 395:66-80, 2002
45. Weibrich G, et al: Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg 30:97-102, 2002
46. Li H, et al: Anterior lumbar interbody fusion with brantigan cages loaded with bioceramics and platelet rich plasma. Orthopaed Res Trans 28:0265, 2003
47. Friedlaender GE, et al: Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg 83A:S151-S158, 2001
48. Boden SD, et al: Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial. Spine 27:2662-2673, 2002
49. Boden SD: Bioactive factors for bone tissue engineering. Clin Orthop 367(Suppl):S84-S94, 1999
50. Street J, et al: Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99:9656-9661, 2002
51. Bouletreau P, et al: Factors in the fracture microenvironment induce primary osteoblast angiogenic cytokine production. Plast Reconstr Surg 110:139-148, 2002
52. Norfleet AM, et al: Thrombin peptide TP508 accelerates closure of dermal excisions in animal tissue with surgically induced ischemia. Wound Repair Regen 8:517-529, 2000
53. Levine BP, et al: Phase I/II evaluation of a thrombin-related peptide for acceleration of distal radius fracture healing. in American Society for Surgery of the Hand Annual Meeting, Phoenix, AZ, 2002